Constellation Brands, Inc. STZ has cash return commitments to shareholders, but a buyout bid for Canopy Growth Corp CGC WEED remains "more likely than not," according to Cantor Fitzgerald.
The Canopy Growth Analyst
Analyst Pablo Zuanic maintained a Neutral rating on Canopy Growth with a CA$27 ($20.73) price target.
The Canopy Growth Thesis
Constellation owns a 35% stake in Canopy totaling 123 million shares, Zuanic said in a Wednesday note. The company also owns four warrants to purchase an additional 159 million Canopy shares, he said. (See the analyst's track record here.)
If Constellation is planning to buy Canopy, then the alcohol giant is looking to make the purchase now, when it would pay roughly CA$6 billion for the company, he said.
If Constellation were to wait, it might pay $25 billion if the share price were hypothetically to reach the high $70s, Zuanic said.
The analyst laid out some bid scenarios.
"If [Constellation] waits for the WEED share price to move to C$77, then it will need to pay C $8Bn to exercise its four sets of warrants (159mn shares), and by then another C$17Bn to own 100% of WEED."
Another option could play out as well, he said.
"On the other hand, after exercising the Nov'17 warrants (if it does) of 18.9mn at C$12.98, it would need to pay "only" ~C$6-7Bn (taking a premium) to own 100% of WEED."
Canopy Growth Price Action
The cannabis stock was trading 2.47% higher to $20.29 at the time of publication Wednesday.
Related Links:
Canopy Growth Analyst Says Constellation Brands Likely To Bid On Cannabis Company's Equity
Constellation Brands Projects 10-Cent Hit To Earnings From Canopy Growth Investment
Photo courtesy of Canopy Growth.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.